false 0001058307 0001058307 2024-05-15 2024-05-15 0001058307 nxpl:CommonStockParValue00001CustomMember 2024-05-15 2024-05-15 0001058307 nxpl:WarrantsCustomMember 2024-05-15 2024-05-15
 


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
 
FORM 8-K
 
CURRENT REPORT
 
PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934
 
DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): May 15, 2024
 
NEXTPLAT CORP
(Exact Name of Registrant as Specified in its Charter)
 
Nevada
 
001-40447
 
65-0783722
(State or Other Jurisdiction
of Incorporation or Organization)
 
(Commission
File No.)
 
(I.R.S. Employer
Identification No.)
 
3250 Mary St., Suite 410
Coconut Grove, FL 33133
(Address of principal executive offices and zip code)
 
(305) 560-5355
(Registrant’s telephone number, including area code)
 
(Former name or former address, if changed from last report)
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
 
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
 
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
 
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
 
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-14(c)).
 
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
 
Emerging growth company
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
 
Securities registered pursuant to Section 12(b) of the Act:
 
Title of each class
 
Trading Symbol (s)
 
Name of each exchange on which registered
Common Stock, par value $0.0001
 
NXPL
 
The Nasdaq Stock Market, Inc.
Warrants
 
NXPLW
 
The Nasdaq Stock Market, Inc.
 


 
 

 
Item 2.02. Results of Operations and Financial Condition
 
On May 15, 2024, NextPlat Corp (the “Registrant”) issued a press release announcing certain financial results for the quarter ended March 31, 2024. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.
 
The information contained herein and in the accompanying exhibit shall not be incorporated by reference into any filing of the Registrant, whether made before or after the date hereof, regardless of any general incorporation language in such filing, unless expressly incorporated by specific reference to such filing. The information in this report, including the exhibit hereto, shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section or Sections 11 and 12(a)(2) of the Securities Act of 1933, as amended.
 
Item 9.01. Financial Statements and Exhibits.
 
Exhibits.
 
Exhibit No.
 
Description
     
99.1
 
104
 
Cover Page Interactive Data File (embedded within the Inline XBRL document)
 
 

 
SIGNATURE
 
Pursuant to the requirements of the Securities and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
NEXTPLAT CORP.
     
 
By:
/s/ Charles M. Fernandez
 
Name:
Charles M. Fernandez
 
Title:
Chairman and Chief Executive Officer
     
Dated: May 15, 2024
   
 
 

Exhibit 99.1

NextPlat Reports Record Consolidated Q1 2024 Revenues of $17.5 Million Compared to $2.9 Million in Q1 2023 (508% Increase) as Quarterly Margins Improve to 27.5%

 

Proposed Merger Agreement with Progressive Care Inc., Launch of its E-Commerce Development Program with Alibabas Tmall Global and Acquisition of Outfitters Expected to Drive Continued Top-Line Growth

 

COCONUT GROVE, FL May 15, 2024 – NextPlat Corp (NASDAQ: NXPL, NXPLW) (“NextPlat” or the “Company”), a global e-Commerce provider, today announced record financial results for the first fiscal quarter ended March 31, 2024 which includes the consolidation of the operations of its e-commerce business with the results of its healthcare operations, Progressive Care Inc. (OTCQB: RXMD) (“Progressive Care”).

 

“First quarter results continued to demonstrate the fundamental strength of NextPlat’s focus on the large healthcare services and global e-commerce technology markets and further demonstrates our team execution against its global growth plans,” said Charles M. Fernandez, Executive Chairman and CEO of NextPlat Corp. “Throughout the remainder of 2024, we are committed to maximizing and unlocking the unrealized value in our business, further building upon the strong financial and technical foundation we have created and our growing list of global partners and customers. We intend to achieve our near-term goals by capitalizing on our ability to significantly improve the efficiency of our business through our proposed merger with Progressive Care and the opportunity to add multiple new high value healthcare and e-commerce revenue streams to our platform.”

 

First Quarter 2024 Financial Highlights:

 

● Consolidated revenues for the quarter ended March 31, 2024, were approximately $17.5 million, an increase of over 508% versus revenue of approximately $2.9 million for the quarter ended March 31, 2024. Results for the first quarter of 2024 reflect e-commerce revenue of approximately $2.9 million and approximately $14.6 million in revenue contributed from the Company’s healthcare operations (specifically, Progressive Care whose results are consolidated as of July 1, 2023).

 

● Gross margins for the quarter ended March 31, 2024, increased significantly to 27.5%, up from 21.6% reported for the quarter ended March 31, 2023, primarily attributable to the healthcare operations because of the Progressive Care consolidation. Gross profit margin attributable to our healthcare operations was approximately 27% (for the consolidation period). Our e-commerce profit margins improved to 28% from 22% reported in the quarter ended March 2024, driven largely by continued increases in the sales of higher margin, recurring airtime revenue.

 

● Operating expenses for the quarter ended March 31, 2024, were approximately $6.7 million compared to approximately $1.9 million in the year-ago period, an increase of approximately $4.8 million. Selling, general and administrative (“SG&A”) increased by approximately $1.2 million and was mainly attributable to the increase in stock-based compensation of approximately $0.4 million, other operating expenses as it relates to the e-Commerce operations of approximately $0.4 million, and approximately $0.4 million as it relates to operating expenses of the healthcare operations as a result of the Progressive Care acquisition on July 1, 2023. Salaries, wages and payroll taxes increased by $2.0 million and was mainly attributable to the healthcare operations as a result of the Progressive Care acquisition as of July 1, 2023. Professional fees, primarily legal and consulting, increased by approximately $0.7 million, and depreciation and amortization expenses increased by approximately $0.7 million.

 

● Net loss for the quarter ended March 31, 2024, was approximately $1.5 million, or ($0.08) per diluted share compared to a net loss of approximately $1.2 million, or ($0.08) diluted earnings per share reported for the quarter ended March 31, 2023.

 

● The Company ended the first quarter of 2024 with approximately $23.5 million in cash.

 

Organizational Highlights and Recent Business Developments:

 

 

In the first quarter, the Company’s technology e-commerce business saw positive sequential quarterly improvement including positive increases in global transaction volumes for satellite phones and tracking devices despite the expected seasonality in the business and continued tight inventory and product availability. Demand for high margin, recurring airtime contracts remains at monthly record levels, driving quarterly margins on airtime sales to near record levels. On April 1, 2024, NextPlat completed the acquisition of Outfitter Satellite Inc. (Outfitter), significantly expanding its North American technology e-commerce business. The Company is actively supporting Outfitter’s new and existing customers while it quickly works to expand and modernize its e-commerce presence including integrating its operations onto its global ERP system expected to be completed by the end of the second quarter.

 

The Company’s healthcare business, Progressive Care, saw a significant 28% increase in revenue in the first quarter of 2024, driven by 16% growth in pharmacy prescriptions and a 110% increase in its 340B contract services business versus the first quarter of 2023.

 

On April 12, 2024, NextPlat announced a proposed business combination with Progressive Care Inc. in an all-stock transaction which is expected to provide revenue synergies and significant annual operating cost reductions. Effective as of July 1, 2023, Progressive Care became a consolidated subsidiary of NextPlat for accounting purposes as a result of the controlling interest in Progressive Care obtained by the Company in concert with the Company’s Executive Chairman and CEO, Charles M. Fernandez, and its Director, Rodney Barreto.

 

The Company’s exclusive OPKO Healthcare (OPKO)-branded storefront in China on Alibabas Tmall Global platform, was launched on March 1, 2024. Since its initial launch, the Company has continued to enhance the OPKO storefront with additional product listings. At launch, the OPKO-branded storefront initially listed health and wellness products including an assortment of nutraceuticals for bone, joint and eye health as well as supplements for nutrition and immunity defense. The OPKO online storefront will see significant expansion with the addition of a wide array of veterinary and animal health products starting in the second quarter of 2024 subject to receipt of the final government approvals. Product marketing programs supported by Alibaba’s local trading partner is expected to commence later in the second quarter.

 

During the quarter, the Company continued to make progress as it prepares for the formal introduction of its Florida Sunshine line of branded vitamins and supplements. This new commerce development program is expected to be launched on Alibaba’s Tmall Global platform in China in the third quarter of 2024, further expanding its e-commerce and healthcare offerings.

 

David Phipps, President of NextPlat and CEO of Global Operations, added, “Healthcare, technology and e-commerce continue to be among the largest and most important sectors of the global economy today and is why NextPlat is committed to investing into near-term opportunities and launching multiple new offerings this year. By leveraging our e-commerce development program with Alibaba and its Tmall Global platform in China, expanding our healthcare footprint for services and products, and adding complementary connectivity offerings to our growing product portfolio, we will continue to demonstrate the strength and value of our diversified business model.”

 

The financial information included in this press release should be read in conjunction with the Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2024, which will be filed with the Securities and Exchange Commission later today.

 

For more information regarding the financial results of Progressive Care Inc. for the quarter ended March 31, 2024, investors should refer to its Quarterly Report on Form 10-Q which will be  filed with the Securities and Exchange Commission later today.

 

About NextPlat Corp

 

NextPlat is a global e-commerce platform company created to capitalize on multiple high-growth sectors and markets including technology and healthcare. Through acquisitions, joint ventures and collaborations, the Company intends to assist businesses in selling their goods online, domestically, and internationally, allowing customers and partners to optimize their e-commerce presence and revenue. NextPlat currently operates an e-commerce communications division offering voice, data, tracking, and IoT products and services worldwide as well as pharmacy and healthcare data management services in the United States through its subsidiary, Progressive Care Inc. (OTCQB: RXMD).

 

Important Information About the Merger and Where to Find It

 

In connection with the proposed merger between NextPlat and Progressive Care, NextPlat intends to file a registration statement/proxy on Form S-4 that will that also will constitute a prospectus of NextPlat with respect to the NextPlat Common Stock to be issued in the proposed transaction (the “proxy statement/prospectus”). The definitive proxy statement/prospectus (if and when available) will be delivered to NextPlat’s and the Progressive Care’s stockholders. NextPlat may also file other relevant documents regarding the proposed transaction with the SEC. NextPlat 's shareholders and other interested persons are advised to read, when available, the proxy statement/prospectus and the amendments thereto and the definitive proxy statement and documents incorporated by reference therein filed in connection with the Merger, as these materials will contain important information about the Progressive Care, NextPlat and the Merger. INVESTORS AND SECURITY HOLDERS OF NEXTPLAT ARE URGED TO READ THESE MATERIALS (INCLUDING ANY AMENDMENTS OR SUPPLEMENTS THERETO) AND ANY OTHER RELEVANT DOCUMENTS IN CONNECTION WITH THE TRANSACTION THAT PROGRESSIVE CARE WILL FILE WITH THE SEC WHEN THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT PROGRESSIVE CARE, NEXTPAT AND THE MERGER. When available, the definitive proxy statement and other relevant materials for the Merger will be mailed to shareholders of NextPlat as of a record date to be established for voting on the Merger and the other related proposals. Shareholders will also be able to obtain copies of the proxy statement/prospectus, the definitive proxy statement and other documents filed with the SEC that will be incorporated by reference therein, without charge, once available, at the SEC’s web site at www.sec.gov, or by directing a request to: NextPlat Corp, 3250 Mary St., Suite 410, Coconut grove, FL 33133, Attention: Chief Financial Officer, Telephone: (305) 560-5355.

 

Participants in the Solicitation

 

NextPlat and its directors and executive officers may be deemed participants in the solicitation of proxies from NextPlat’s shareholders with respect to the Merger. A list of the names of those directors and executive officers and a description of their interests in NextPlat is contained in NextPlat’s Annual Report on Form 10-K filed with the SEC on April 11, 2024 and is available free of charge at the SEC’s web site at www.sec.gov, or by directing a request to NextPlat Corp, 3250 Mary St., Suite 410, Coconut grove, FL 33133, Attention: Chief Financial Officer, Telephone: (305) 560-5355. Additional information regarding the interests of such participants will be contained in the proxy statement for the Merger when available.

 

Progressive Care and its directors and executive officers may also be deemed to be participants in the solicitation of proxies from the shareholders of NextPlat in connection with the Merger. A list of the names of such directors and executive officers and information regarding their interests in the Merger will be included in the proxy statement for the Merger when available.

 

No Offer or Solicitation

 

This Current Report on Form 8-K shall not constitute a solicitation of a proxy, consent or authorization with respect to any securities or in respect of the Merger. This Current Report on Form 8-K shall also not constitute an offer to sell or the solicitation of an offer to buy any securities, nor shall there be any sale of securities in any states or jurisdictions in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. No offering of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act, or an exemption therefrom.

 

Forward-Looking Statements

 

Certain statements in this release constitute forward-looking statements. These statements include the capabilities and success of the Company’s business and any of its products, services or solutions. The words “believe,” “forecast,” “project,” “intend,” “expect,” “plan,” “should,” “would,” and similar expressions and all statements, which are not historical facts, are intended to identify forward-looking statements. These forward-looking statements involve and are subject to known and unknown risks, uncertainties and other factors, including the Company’s ability to launch additional e-commerce capabilities for consumer and healthcare products  and its ability to grow and expand as intended, any of which could cause the Company to not achieve some or all of its goals or the Company’s previously reported actual results, performance (finance or operating), including those expressed or implied by such forward-looking statements. More detailed information about the Company and the risk factors that may affect the realization of forward-looking statements is set forth in the Company’s filings with the Securities and Exchange Commission (the “SEC”), copies of which may be obtained from the SEC’s website at www.sec.gov. The Company assumes no, and hereby disclaims any, obligation to update the forward-looking statements contained in this press release.

 

Media and Investor Contact for NextPlat Corp:

 

Michael Glickman

 

MWGCO, Inc.

 

917-397-2272

 

mike@mwgco.net

 

 

 

NEXTPLAT CORP AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)

(In thousands, except per share data)

   

Three Months Ended

   

Three Months Ended

 
   

March 31, 2024

   

March 31, 2023

 
   

(Unaudited)

   

(Unaudited)

 
                 

Sales of products, net

  $ 14,120     $ 2,876  

Revenues from services

    3,373       -  

Revenue, net

    17,493       2,876  
                 

Cost of products

    12,620       2,255  

Cost of services

    63       -  

Cost of revenue

    12,683       2,255  
                 

Gross profit

    4,810       621  
                 

Operating expenses:

               

Selling, general and administrative

    2,005       788  

Salaries, wages and payroll taxes

    2,624       588  

Impairment loss

    132       -  

Professional fees

    985       321  

Depreciation and amortization

    906       162  

Total operating expenses

    6,652       1,859  
                 

Loss before other (income) expense

    (1,842 )     (1,238 )
                 

Other (income) expense:

               

Interest expense

    21       5  

Interest earned

    (215 )     (10 )

Other income

    -       (50 )

Foreign currency exchange rate variance

    26       (28 )

Total other income

    (168 )     (83 )
                 

Loss before income taxes and equity in net loss of affiliate

    (1,674 )     (1,155 )
                 

Income taxes

    (27 )     -  

Loss before equity in net loss of affiliate

    (1,701 )     (1,155 )
                 

Equity in net loss of affiliate

    -       (32 )

Net loss

    (1,701 )     (1,187 )
                 

Net loss attributable to non-controlling interest

    220       -  

Net loss attributable to NextPlat Corp

  $ (1,481 )   $ (1,187 )
                 

Comprehensive income (loss):

               

Net loss

  $ (1,701 )   $ (1,187 )

Foreign currency loss

    (27 )     (23 )

Comprehensive loss

  $ (1,728 )   $ (1,210 )
                 

NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS

  $ (1,481 )   $ (1,187 )

Weighted number of common shares outstanding – basic and diluted

    18,725       14,415  
                 

Loss per share - basic and diluted

  $ (0.08 )   $ (0.08 )

 

 

NEXTPLAT CORP AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

(In thousands, except shares and par data)

   

March 31, 2024

   

December 31, 2023

 
   

(Unaudited)

   

(Audited)

 

ASSETS

               

Current Assets

               

Cash

  $ 23,526     $ 26,307  

Accounts receivable, net

    12,928       8,923  

Receivables - other, net

    2,068       1,846  

Inventory, net

    5,610       5,135  

Unbilled revenue

    185       189  

VAT receivable

    357       342  

Prepaid expenses

    404       640  

Notes receivable due from related party

    260       256  

Total Current Assets

    45,338       43,638  
                 

Property and equipment, net

    3,846       3,989  
                 

Goodwill

    731       731  

Intangible assets, net

    13,725       14,423  

Operating right of use assets, net

    1,303       1,566  

Finance right-of-use assets, net

    18       22  

Deposits

    39       39  

Prepaid expenses, net of current portion

    61       61  

Total Other Assets

    15,877       16,842  

Total Assets

  $ 65,061     $ 64,469  
                 

LIABILITIES AND EQUITY

               
                 

Current Liabilities

               

Accounts payable and accrued expenses

  $ 14,893     $ 13,176  

Contract liabilities

    140       42  

Notes payable

    233       312  

Due to related party

    42       18  

Operating lease liabilities

    532       532  

Finance lease liabilities

    20       18  

Income taxes payable

    90       139  

Total Current Liabilities

    15,950       14,237  
                 

Long Term Liabilities:

               

Notes payable, net of current portion

    1,165       1,211  

Operating lease liabilities, net of current portion

    853       929  

Finance lease liabilities, net of current portion

    -       5  

Total Liabilities

    17,968       16,382  
                 

Commitments and Contingencies

    -       -  
                 

Equity

               

Preferred stock ($0.0001 par value; 3,333,333 shares authorized)

    -       -  

Common stock ($0.0001 par value; 50,000,000 shares authorized, 18,724,596 and 18,724,596 shares issued and outstanding as of March 31, 2024 and December 31, 2023, respectively)

    2       2  

Additional paid-in capital

    67,717       67,170  

Accumulated deficit

    (36,406 )     (34,925 )

Accumulated other comprehensive loss

    (90 )     (63 )

Equity attributable to NextPlat Corp stockholders

    31,223       32,184  

Equity attributable to non-controlling interests

    15,870       15,903  

Total Equity

    47,093       48,087  
                 

Total Liabilities and Equity

  $ 65,061     $ 64,469  
 
v3.24.1.1.u2
Document And Entity Information
May 15, 2024
Document Information [Line Items]  
Entity, Registrant Name NEXTPLAT CORP
Document, Type 8-K
Document, Period End Date May 15, 2024
Entity, Incorporation, State or Country Code NV
Entity, File Number 001-40447
Entity, Tax Identification Number 65-0783722
Entity, Address, Address Line One 3250 Mary St., Suite 410
Entity, Address, City or Town Coconut Grove
Entity, Address, State or Province FL
Entity, Address, Postal Zip Code 33133
City Area Code 305
Local Phone Number 560-5355
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Entity, Emerging Growth Company false
Amendment Flag false
Entity, Central Index Key 0001058307
CommonStockParValue00001 Custom [Member]  
Document Information [Line Items]  
Title of 12(b) Security Common Stock, par value $0.0001
Trading Symbol NXPL
Security Exchange Name NASDAQ
Warrants Custom [Member]  
Document Information [Line Items]  
Title of 12(b) Security Warrants
Trading Symbol NXPLW
Security Exchange Name NASDAQ

NextPlat (NASDAQ:NXPLW)
Historical Stock Chart
From Oct 2024 to Nov 2024 Click Here for more NextPlat Charts.
NextPlat (NASDAQ:NXPLW)
Historical Stock Chart
From Nov 2023 to Nov 2024 Click Here for more NextPlat Charts.